Publications by authors named "Jaskaran S Dhillon"
Article Synopsis
- Buprenorphine/naloxone (Suboxone) is recognized as the primary treatment for opioid use disorder (OUD), but until 2023, prescribing it required a special certification (X-Waiver) that limited the number of patients a doctor could treat.
- The Consolidated Appropriations Act of 2023 removed these restrictions, allowing buprenorphine/naloxone to be prescribed like other opioids, aiming to improve access to treatment for OUD.
- Despite the legislative changes, further efforts are needed—such as reducing stigma and improving institutional support—to truly enhance the treatment experience and outcomes for patients with OUD.
Importance: The total cost of psoriasis in the United States is unknown. Defining the US economic burden of psoriasis is needed because it provides the foundation for research, advocacy, and educational efforts.
Objective: To determine the US economic burden of psoriasis from a societal perspective.
Background: Streptococcal infection is associated with psoriasis onset in some patients. Whether tonsillectomy decreases psoriasis symptoms requires a systematic review of the literature.
Objective: We sought to determine whether tonsillectomy reduces psoriasis severity through a comprehensive search of over 50 years of literature.